drugset / Trial / NCT00979849

AZD8683 Single Ascending Dose Study

NCT00979849

Phase 1 Completed 130 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8683 following single ascending dose administrations in healthy male subjects.

Timeline

Start
2009-10
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8683 Unknown 1 ug Inhaled

Indications

No indication recorded.